PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31853327-0	2020	Dexamethasone and lenvatinib inhibit migration and invasion of non-small cell lung cancer by regulating EKR/AKT and VEGF signal pathways.	Dexamethasone	0-13	AKT serine/threonine kinase 1	Homo sapiens	108-111	
31853327-13	2020	Notably, the results demonstrated that dexamethasone eradicated the promotion effects of TGF-beta1 on the AKT/epithelial-mesenchymal transition process and lenvatinib extinguished tumor cell metastasis by targeting VEGF.	Dexamethasone	39-52	AKT serine/threonine kinase 1	Homo sapiens	106-109	
31853327-16	2020	In conclusion, dexamethasone inhibited AKT/ERK phosphorylation and lenvatinib antagonism bound VEGF leading to the limitation of migration and invasion of cancer cells in NSCLC.	Dexamethasone	15-28	AKT serine/threonine kinase 1	Homo sapiens	39-42